检索结果 - Matthieu Ruffin

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Treatment with pasireotide LAR normalizes prolactin levels in patients with acromegaly and hyperprolactinemia: randomized, double-blind, 12-month, phase III study

    Treatment with pasireotide LAR normalizes prolactin levels in patients with acromegaly and hyperprolactinemia: randomized, double-blind, 12-month, phase III study 由 Annamaria Colao, Pamela U. Freda, Feng Gu, Karina Hermosillo Reséndiz, Matthieu Ruffin, YinMiao Chen, Marcello D. Bronstein

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Pasireotide LAR and octreotide LAR maintain inhibition of GH and IGF1 in patients with acromegaly: 12-month extension phase of a randomized, double-blind, multicenter, phase III study

    Pasireotide LAR and octreotide LAR maintain inhibition of GH and IGF1 in patients with acromegaly: 12-month extension phase of a randomized, double-blind, multicenter, phase III st... 由 Michael C. Sheppard, Marcello D. Bronstein, Pamela U. Freda, Omar Serri, Marinis Laura De, Luciana Ansaneli Naves, Liudmila Rozhinskaya, Resendiz Karina Hermosillo, Matthieu Ruffin, Kobby Asubonteng, Annamaria Colao

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

    Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multic... 由 Michael C. Sheppard, Marcello D. Bronstein, Pamela U. Freda, Omar Serri, Laura De Marinis, Luciana Ansaneli Naves, Liudmila Rozhinskaya, Karina Hermosillo Reséndiz, Matthieu Ruffin, YinMiao Chen, Annamaria Colao

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

    Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-b... 由 Michael C. Sheppard, Marcello D. Bronstein, Pamela U. Freda, Omar Serri, Laura De Marinis, Luciana Ansaneli Naves, Liudmila Rozhinskaya, Karina Hermosillo Reséndiz, Matthieu Ruffin, YinMiao Chen, Annamaria Colao

    出版 2015
    获取全文 获取全文
    Errata/Corrigenda
    加到收藏夹
    Saved in:
  5. 5
    Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study

    Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study 由 Stephan Petersenn, Andrew J. Farrall, Christophe De Block, Шломо Мелмед, Jochen Schopohl, Philippe Caron, Ross C. Cuneo, David L. Kleinberg, Annamaria Colao, Matthieu Ruffin, Karina Hermosillo Reséndiz, Gareth Hughes, Ke Hu, Ariel L. Barkan

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

    Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study 由 Marcello D. Bronstein, Maria Fleseriu, Sebastian Neggers, Annamaria Colao, Michael C. Sheppard, Feng Gu, Chiung‐Chyi Shen, Mônica R. Gadelha, Andrew J. Farrall, Karina Hermosillo Reséndiz, Matthieu Ruffin, YinMiao Chen, Pamela U. Freda

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

    Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study 由 Annamaria Colao, Marcello D. Bronstein, Pamela U. Freda, Feng Gu, Chiung‐Chyi Shen, Mônica R. Gadelha, Maria Fleseriu, A. J. van der Lely, Andrew J. Farrall, Karina Hermosillo Reséndiz, Matthieu Ruffin, Yixin Chen, Mary N. Sheppard

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Switching patients with acromegaly from octreotide LAR to pasireotide LAR improves biochemical control: crossover extension to a randomized, double-blind, multicenter, Phase III study

    Switching patients with acromegaly from octreotide LAR to pasireotide LAR improves biochemical control: crossover extension to a randomized, double-blind, multicenter, Phase III st... 由 Pamela U. Freda, Maria Fleseriu, der Lely Aart Jan van, Annamaria Colao, Michael C. Sheppard, Feng Gu, Chiung‐Chyi Shen, Mônica R. Gadelha, Andrew J. Farrall, Resendiz Karina Hermosillo, Matthieu Ruffin, YinMiao Chen, Marcello D. Bronstein

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: